Boris Rachev

Background

About Boris Rachev

Senior leader with executive experience and more than 20 years of pharmaceutical and healthcare consulting and business development experience focusing on healthcare economics and quantitative analysis, health policy and systems, government healthcare programs, predictive analytics. Throughout my career I have been in thought leadership roles, as well as practice manager, project director, and principal investigator. I am proficient in solving complex problems using a broad range of quantitative skills, abstract concepts, and applied analytical tools. I have broad experience in the design and implementation of large-scale, multi-year research projects. My expertise in research methods includes health economic modeling, econometrics, indirect treatment comparison (network meta-analysis), factor analysis, propensity scoring, multiple imputation, generalized linear and additive models, and other quantitative tools. I'm proficient in R, STATA, SPSS and SAS programming languages. I'm also a published author and health industry strategist with years of thought leadership and hands-on experience in economic and policy analysis, including the recently adopted Inflation Reduction Act (IRA). Expert knowledge and understanding of changing health care regulations and health policy, globally (NICE, HAS, EUNETHTA, CADTH, PBAC, IQWIG, etc.) and domestically (CMS, HHS, HRSA, ARHQ, ICER). I have extensive US, Canada, UK, continental Europe, China, ANZ, and other global health sector markets. Specialties: health economics and outcomes research, pharmacoeconomics, public policy, IRA, quantitative analysis, survey research, econometrics, statistics, languages